Form 4: Jack Henry Director Granted 1,220 Restricted Stock Units
Statement of Changes in Beneficial Ownership
Jack Henry & Associates Director Matthew C. Flanigan received a grant of 1,220 restricted stock units, vesting in 2026.
Summary
- Matthew C. Flanigan, a Director of Jack Henry & Associates Inc. (JKHY), was granted 1,220 restricted stock units (RSUs).
- The transaction date for this grant was November 17, 2025.
- Each restricted stock unit is economically equivalent to one share of JKHY common stock and represents a contingent right to receive one share of common stock or its cash value.
- The RSUs will vest in full on the earlier of the day before the Issuer's 2026 Annual Meeting of Stockholders or the first anniversary of the grant date (November 17, 2026).
Sentiment
Score: 6
Explanation: The filing reports a routine equity grant to a director, which is a standard compensation practice. This is generally viewed as neutral to slightly positive as it aligns the director's interests with shareholders, without indicating any significant new operational or financial developments.
Positives
- The grant of restricted stock units to a director aligns their interests with those of the shareholders, encouraging long-term value creation.
Future Outlook
The restricted stock units are scheduled to vest in full on the earlier of the day before the Issuer's 2026 Annual Meeting of Stockholders or November 17, 2026, indicating future equity ownership for the director.
Industry Context
The grant of restricted stock units to a director is a common practice in the financial services technology industry and broader corporate landscape, serving as a form of equity-based compensation to attract, retain, and incentivize key personnel.
Comparison to Industry Standards
- Equity grants, such as restricted stock units, are a standard component of director compensation packages across publicly traded companies, including those in the financial technology sector like Jack Henry & Associates.
- The vesting schedule, often tied to a specific period or the next annual meeting, is also a typical structure for such grants, aligning with common corporate governance practices for non-employee directors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Grant of 1,220 restricted stock units to Director Matthew C. Flanigan as part of his compensation package. | 11/17/2025 | This is a standard practice for director compensation, intended to align the director's long-term interests with those of the company's shareholders. |
Related Party Transactions
- Grant of 1,220 restricted stock units to Director Matthew C. Flanigan, a related party, as part of his standard compensation package.
Stakeholder Impact
- Shareholders: The grant aligns the director's financial interests with shareholder value creation, as the value of the RSUs is tied to the company's stock performance.
Next Steps
- The restricted stock units will vest on the earlier of the day before the Issuer's 2026 Annual Meeting of Stockholders or November 17, 2026.
Key Dates
| Date | Description |
|---|---|
| 11/17/2025 | Date of grant for 1,220 restricted stock units to Matthew C. Flanigan. |
| 11/18/2025 | Date of signature for the Form 4 filing by Power of Attorney for Matthew C. Flanigan. |
| 11/17/2026 | Latest possible vesting date for the restricted stock units (first anniversary of grant date). |
| 2026 | Year of the Issuer's Annual Meeting of Stockholders, which is an alternative vesting trigger for the restricted stock units. |
Recommendation
holdThis Form 4 reports a routine equity grant to a director as part of their compensation, which is a standard practice and does not provide new information warranting a change in investment recommendation. The transaction is not considered price-sensitive.
Keywords
Jack Henry, JKHY, Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.